Xinjiang Baihuacun Pharmaceutical Group Competitors and Similar CompaniesClear all

Xinjiang Baihuacun Pharmaceutical Group's competitors and similar companies include KABS Laboratories, Clinical Trial Service, Indoco Remedies and Aristo Pharmaceuticals.

	Xinjiang Baihuacun Pharmaceutical Group Xinjiang Baihuacun (新疆百花村医药集团股份有限公司) is a company that provides engages in the pharmaceutical research and development business.	KABS Laboratories KABS Laboratories is a provider of product development services to the biopharmaceutical industry.	Clinical Trial Service Clinical Trial Service is a pharmaceutical company.	Indoco Remedies Indoco Remedies is a provider of healthcare products and services.	Aristo Pharmaceuticals Aristo Pharmaceuticals is a manufacturer and supplier of medicinal products.
Founding Date	Founding Date 1956	Founding Date 1997	Founding Date 1993	Founding Date 1947	Founding Date 1971
Type	Type Public	Type Private	Type Private	Type Public	Type Private
Tags	Tags Healthcare clinical research pharma pharmacy	Tags Healthcare clinical research pharmacy	Tags Healthcare clinical research pharma pharmacy	Tags Healthcare clinical research pharma pharmacy	Tags Healthcare clinical research pharma pharmacy
Locations	Locations Urumqi, CN HQ	Locations Longueuil, CA HQ	Locations Losser, NL HQ	Locations Hyderabad, IN HQ Mumbai, IN	Locations Mumbai, IN HQ Bhopal, IN Daman, IN Mumbai, IN
Employees	Employees 731	Employees 972% increase	Employees 29	Employees 6,002	Employees 3,3832% increase
Financial
Revenue (est.)	Revenue (est.) ¥382.3m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹16.4b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods ¥211.5m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹5b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit ¥171.7m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit ₹11.5b (FY, 2025)	Gross profit N/A
Net income	Net income ¥40.7m (FY, 2025)	Net income N/A	Net income N/A	Net income (₹779.5m) (FY, 2025)	Net income N/A